Terremoto Biosciences Inc.
2 clinical trials · Sponsor
◉ Watch Terremoto Biosciences Inc.
| Record | Firm | Date |
|---|---|---|
| A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia (NCT07255846) | Terremoto Biosciences Inc. | 2025-12-15 |
| A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations (NCT07109726) | Terremoto Biosciences Inc. | 2025-09-23 |
Track Terremoto Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.